did I read correctlyin the announcementthe possibility of the share price being 25c25c now that sounds positivewe should see quite a bit of upward movement in the next 2 weeksimo
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%